4.7 Article

Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder

Journal

EBIOMEDICINE
Volume 66, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.ebiom.2021.103337

Keywords

Major depressive disorder; Biomarker; Circular RNAs; Antidepressive treatment; Brain-derived neurotrophic factor; Amplitude of low-frequency fluctuation; Neuropsychological assessment; Competing endogenous RNA

Funding

  1. National Key Research and Development Plan of China [2016YFC1306700]

Ask authors/readers for more resources

The study found that circFKBP8 and circMBNL1 in whole-blood samples could be potential biomarkers for the diagnosis of major depressive disorder (MDD). CircFKBP8 may also have great potential for antidepressive treatment according to the results of an interventional study on MDD patients.
Background: circular RNAs (circRNAs) are expressed abundantly in the brain and are implicated in the pathophysiology of neuropsychiatric disease. However, the potential clinical value of circRNAs in major depressive disorder (MDD) remains unclear. Methods: RNA sequencing was conducted in whole-blood samples in a discovery set (7 highly homogeneous MDD patients and 7 matched healthy controls [HCs]). The differential expression of circRNAs was verified in an independent validation set. The interventional study was conducted to assess the potential effect of the antidepressive treatment on the circRNA expression. Findings: in the validation set, compared with 52 HCs, significantly decreased circFKBP8 levels (Diff:-0.24; [95% CI-0.39 --0.09])and significantly elevated circMBNL1 levels (Diff: 0.37; [95% CI 0.09 -0.64]) were observed in 53 MDD patients. The expression of circMBNL1 was negatively correlated with 24-item Hamilton Depression Scale (HAMD-24) scores in 53 MDD patients. A mediation model indicated that circMBNL1 affected HAMD-24 scores through a mediator, serum brain-derived neurotrophic factor. In 53 MDD patients, the amplitude of low-frequency fluctuations in the right orbital part middle frontal gyrus was positively correlated with circFKBP8 and circMBNL1 expression. Furthermore, the interventional study of 53 MDD patients demonstrated that antidepressive treatment partly increased circFKBP8 expression and the change in expression of circFKBP8 was predictive of further reduced HAMD-24 scores. Interpretation: whole-blood circFKBP8 and circMBNL1 may be potential biomarkers for the diagnosis of MDD, respectively, and circFKBP8 may show great potential for the antidepressive treatment. (C) 2021 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available